Abstract Background: Research on cannabis‐based medicinal products (CBMPs) in anxiety remains inconclusive due to a paucity of high‐quality evidence. Studies…
Abstract Introduction: While there is increasing evidence of the effects of cannabis‐based medicinal products (CBMPs) on health‐related quality of life…
Abstract Introduction: Estimated rates of past-month cannabidiol (CBD) use in the general public are 13–26% and emerging research examines CBD…
Abstract Cannabis is well established to impact affective states, emotion and perceptual processing, primarily through its interactions with the endocannabinoid…
Abstract Endocannabinoids were implicated in a variety of pathological conditions including anxiety and are considered promising new targets for anxiolytic…
Abstract Background: Use of cannabis during pregnancy and breastfeeding is increasing. Mental health concerns are reported as common reasons for…
Abstract This report documents the case of a patient (the author) participating in a clinical trial of medical cannabis (Cannabis…
Abstract Cannabis has shown therapeutic potential in mood and anxiety-related pathologies. However, the two primary constituents of cannabis, cannabidiol (CBD)…
Abstract Background: Compelling evidence from preclinical and clinical studies supports the therapeutic role of cannabidiol (CBD) in several medical disorders.…
Abstract Background: Substance use and its associated bio-psycho-social problems are public health concerns with harmful individual and social consequences. Objective:…